Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder | Zendy

Yi Chen | Zendy; Liu | Zendy; Faries | Zendy

Open Access

Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder

Author(s) -

Yi Chen,

Liu,

Faries

Publication year - 2011

Publication title -

clinicoeconomics and outcomes research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.591

H-Index - 27

ISSN - 1178-6981

DOI - 10.2147/ceor.s17846

Subject(s) - escitalopram , duloxetine , venlafaxine , persistence (discontinuity) , major depressive disorder , medicine , duloxetine hydrochloride , citalopram , psychiatry , logistic regression , generalized anxiety disorder , anxiety , antidepressant , mood , alternative medicine , geotechnical engineering , pathology , engineering

THIS STUDY COMPARED ADHERENCE AND PERSISTENCE OF THREE BRANDED ANTIDEPRESSANTS: the serotonin and norepinephrine reuptake inhibitors (SNRIs) duloxetine and venlafaxine XR, and the selective serotonin reuptake inhibitor (SSRI) escitalopram; and generic selective SSRIs, and examined demographic and clinical predictors of adherence and persistence in patients with major depressive disorder in usual care settings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research